U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507422) titled 'Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy' on March 27.
Brief Summary: The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Study Start Date: April 17
Study Type: OBSERVATIONAL
Condition:
Chronic Pain
Intractable Pain
Intervention:
DEVICE: Commercially available Inceptiv™ neurostimulation systems
Spinal cord stimulation therapy deliver...